Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
25.89
-1.10 (-4.08%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Mineralys Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 2,135 | 2,872 | 613 | 354 | - | - | |
| Market Cap Growth | 169.93% | 368.78% | 73.31% | - | - | - | |
| Enterprise Value | 1,478 | 2,278 | 349 | 100 | - | - | |
| Last Close Price | 25.89 | 36.29 | 12.31 | 8.60 | - | - | |
| PB Ratio | 3.26 | 4.44 | 3.20 | 1.47 | - | - | |
| P/TBV Ratio | 3.30 | 4.44 | 3.20 | 1.47 | - | - | |
| Net Debt / Equity Ratio | -1.01 | -1.01 | -1.04 | -0.98 | -1.03 | -1.75 | |
| Net Debt / EBITDA Ratio | 3.85 | 3.85 | 1.03 | - | - | - | |
| Net Debt / FCF Ratio | 4.61 | 4.61 | 1.19 | 2.91 | 3.77 | 0.73 | |
| Quick Ratio | 43.45 | 43.45 | 13.53 | 22.57 | 13.65 | 2.10 | |
| Current Ratio | 43.76 | 43.76 | 14.02 | 23.77 | 13.98 | 2.20 | |
| Return on Equity (ROE) | -36.91% | -36.91% | -82.24% | -41.38% | -53.00% | -1568.96% | |
| Return on Assets (ROA) | -24.58% | -24.58% | -52.56% | -28.91% | -31.34% | -185.60% | |
| Return on Capital Employed (ROCE) | -26.40% | -26.40% | -100.60% | -35.10% | -29.60% | -308.40% | |
| Earnings Yield | -7.24% | -5.38% | -29.02% | -20.34% | - | - | |
| FCF Yield | -6.67% | -4.96% | -27.16% | -22.96% | - | - | |
| Buyback Yield / Dilution | -39.38% | -39.38% | -34.13% | -600.33% | -3.67% | -7.64% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.